st jude eon mini dorsal column stimulator

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. The ANS Division is an innovative technology leader dedicated to the design, development, manufacturing and marketing of implantable neuromodulation systems to improve the quality of life for people suffering from disabling chronic pain and other nervous system disorders (Forward-Looking Statements The ANS Division (Advanced Neuromodulation Systems) became part of St. For more information, please visit About the ANS Division of St. Jude Medical employs more than 12,500 people worldwide and has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The American Pain Foundation estimates that chronic pain costs approximately $100 billion per year in lost work time and health care expenses. According to the National Institutes of Health, 90 million people in the U.S.

Patients can obtain more information about neurostimulation pain therapies at Pain is a serious and costly public health issue, and it remains largely under-treated and misunderstood. More than 35,000 patients in 35 countries have been implanted with St. Similar in function and appearance to cardiac pacemakers, these devices deliver mild electrical pulses to the spinal cord, interrupting or masking the pain signals' transmission to the brain. Neurostimulators like EonC are designed to provide SCS therapy to treat complex neuropathic pain of the trunk and limbs or pain from failed back surgeries. The new device complements Eon®, a high-capacity, rechargeable device, and Eon Mini™, the world's smallest, longest-lasting rechargeable neurostimulator. With the addition of EonC to its product portfolio, ANS now provides an even more comprehensive line of SCS devices to meet the needs of chronic pain patients. High power and high pulse frequencies which enable clinicians to adjust the therapy to accommodate individual patient needsĮonC is the only 16-contact, constant current, non-rechargeable system for SCS therapy.Constant current circuitry which automatically adjusts power output to deliver consistent therapy over time.

Advanced programming capability which allows patients to adjust therapy strength in up to eight pain areas simultaneously and independently.

Proprietary technology (called NeuroDynamix™) which helps deliver stimulation with greater efficiency.

The EonC system's patient benefits include: For some patients, a non-rechargeable device like EonC provides the perfect solution for their needs.' 'With chronic pain, there's no such thing as a ‘one size fits all' approach. 'Selecting the right system for each patient is vital for the success of spinal cord stimulation (SCS) therapy,' said Chris Chavez, president of the St. Featuring the greatest battery capacity of any primary cell neurostimulator, the EonC may maximize the time between device replacement procedures. The EonC neurostimulator provides a convenient option for chronic pain patients who prefer or require the simplicity of a non-rechargeable medical device. Food and Drug Administration (FDA) and European CE Mark approvals of EonC™, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.

St jude eon mini dorsal column stimulator